OKTA vs REPL · P/E 84, rev $2.61B vs $825.7M cap
Okta Inc (OKTA) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
Okta Inc (OKTA) is a software - infrastructure company listed on NASDAQ.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported OKTA revenue for 2025-01-31 was $2.61B. Net income was $28.0M. Revenue was up 15.3% from 2024-01-31 to 2025-01-31. OKTA currently screens at market cap $20.06B and trailing P/E 83.6.
REPL does not have a complete income-statement cache yet.
OKTA currently screens at market cap $20.06B and trailing P/E 83.6. REPL currently screens at market cap $825.7M.
Not investment advice. Open the OKTA and REPL stock pages for the full models.
Not investment advice.